Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats

被引:25
|
作者
Rodriguez, Francisca [1 ]
Lopez, Bernardo [1 ]
Perez, Cayetano [1 ]
Fenoy, Francisco J. [1 ]
Hernandez, Isabel [1 ]
Stec, David E. [2 ]
Volti, Giovanni Li [3 ]
Salom, Miguel G. [1 ]
机构
[1] Univ Murcia, Murcia Sch Med, Dept Physiol, E-30100 Murcia, Spain
[2] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Ctr Excellence Cardiovasc Renal Res, Jackson, MS 39216 USA
[3] Univ Catania, Fac Pharm, Biochem Sect, Dept Drug Sci, Catania, Italy
关键词
oxidative stress; nitrotyrosine; type-1; diabetes; NITRIC-OXIDE SYNTHESIS; CARBON-MONOXIDE; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; AFFERENT ARTERIOLES; KIDNEY; INCREASE; INDUCTION; RESTORES; MELLITUS;
D O I
10.1152/ajpregu.00847.2010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Rodriguez F, Lopez B, Perez C, Fenoy FJ, Hernandez I, Stec DE, Li Volti G, Salom MG. Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats. Am J Physiol Regul Integr Comp Physiol 301: R1540 -R1548, 2011. First published August 17, 2011; doi:10.1152/ajpregu.00847.2010.-Heme oxygenase-1 (HO-1) is induced by oxidative stress and plays an important role in protecting the kidney from oxidant-mediated damage in the streptozotocin (STZ) rat model of type-1 diabetes mellitus (DM-1). HO-derived metabolites, presumably carbon monoxide (CO), mediate vasodilatory influences in the renal circulation, particularly in conditions linked to elevated HO-1 protein expression or diminished nitric oxide (NO) levels. We tested the hypothesis that diabetes increases oxidative stress and induces HO-1 protein expression, which contributes to regulate renal hemodynamics in conditions of low NO bioavailability. Two weeks after the induction of diabetes with STZ (65 mg/kg iv), Sprague-Dawley rats exhibited higher renal HO-1 protein expression, hyperglycemia, and elevated renal nitrotyrosine levels than control normoglycemic animals. In anesthetized diabetic rats, renal vascular resistance (RVR) was increased, and in vivo cortical NO levels were reduced (P < 0.05) compared with control animals. Acute administration of the HO inhibitor Stannous mesoporphyrin (SnMP; 40 mu mol/kg iv) did not alter renal hemodynamics in control rats, but greatly decreased glomerular filtration rate and renal blood flow, markedly increasing RVR in hyperglycemic diabetic rats. Chronic oral treatment with the SOD mimetic tempol prevented the elevation of nitrotyrosine, the HO-1 protein induction, and the increases in RVR induced by SnMP in the diabetic group, without altering basal NO concentrations or RVR. Increasing concentrations of a CO donor (CO-releasing molecule-A1) on pressurized renal interlobar arteries elicited a comparable relaxation in vessels taken from control or diabetic animals. These results suggest that oxidative stress-induced HO-1 exerts vasodilatory actions that partially maintain renal hemodynamics in uncontrolled DM-1.
引用
收藏
页码:R1540 / R1548
页数:9
相关论文
共 50 条
  • [1] Chronic Tempol treatment prevents the renal vasoconstriction induced by a heme oxygenase inhibitor in Streptozotocin diabetic rats
    Rodriguez, Francisca
    Lopez, Bernardo
    Nieto, Susana
    Salom, Miguel G.
    Hernandez, Isabel
    Fenoy, Francisco J.
    FASEB JOURNAL, 2008, 22
  • [2] Sexual Dimorphism in the Renal Hemodynamic Response to a Heme Oxygenase Inhibitor in Diabetic Rats
    Lopez, Bernardo
    Hernandez, Jose L.
    Bonacasa, Barbara
    Fenoy, Francisco J.
    Salom, Miguel G.
    Hernandez, Isabel
    Rodriguez, Francisca
    HYPERTENSION, 2010, 56 (05) : E160 - E160
  • [3] Sexual Dimorphism in Renal Heme-Heme Oxygenase System in the Streptozotocin Diabetic Rats
    Bonacasa, Barbara
    Perez, Cayetano
    Salom, Miguel G.
    Lopez, Bernardo
    Saez-Belmonte, Fara
    Martinez, Pedro
    Casas, Teresa
    Fenoy, Francisco J.
    Rodriguez, Francisca
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (15) : 2678 - 2686
  • [4] Renal Protection of In Vivo Administration of Tempol in Streptozotocin-Induced Diabetic Rats
    Luan, Jiajie
    Li, Weiping
    Han, Jia
    Zhang, Wen
    Gong, Huiling
    Ma, Rong
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 119 (02) : 167 - 176
  • [5] EFFECTS OF CHRONIC NIFEDIPINE TREATMENT ON STREPTOZOTOCIN-INDUCED DIABETIC RATS
    SHAH, TS
    SATIA, MC
    GANDHI, TP
    BANGARU, RA
    GOYAL, RK
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (01) : 6 - 12
  • [6] Targeting heme oxygenase-1 in early diabetic nephropathy in streptozotocin-induced diabetic rats
    El Gheit, R. Abo
    Emam, M. N.
    PHYSIOLOGY INTERNATIONAL, 2016, 103 (04) : 413 - 427
  • [7] Genistein attenuates renal fibrosis in streptozotocin-induced diabetic rats
    Jia, Qiang
    Yang, Rui
    Liu, Xiao-Fen
    Ma, Shan-Feng
    Wang, Lei
    MOLECULAR MEDICINE REPORTS, 2019, 19 (01) : 423 - 431
  • [8] Protective effects of chronic melatonin treatment against renal injury in streptozotocin-induced diabetic rats
    Cam, M
    Yavuz, Ö
    Guven, A
    Ercan, F
    Bukan, N
    Üstündag, N
    JOURNAL OF PINEAL RESEARCH, 2003, 35 (03) : 212 - 220
  • [9] Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats
    Wang, Furong
    Li, Mei
    Cheng, Lin
    Zhang, Tingguo
    Hu, Jianting
    Cao, Mingfeng
    Zhao, Jiajun
    Guo, RuiChen
    Gao, Ling
    Zhang, Xiumei
    LIFE SCIENCES, 2008, 83 (25-26) : 828 - 835
  • [10] Glycine attenuates renal oxidative stress in streptozotocin-induced diabetic rats
    Wang, Z.
    Zhang, J.
    Wang, L.
    Li, W.
    Chen, L.
    Li, J.
    Zhao, D.
    Zhang, H.
    Guo, X.
    DIABETOLOGIA, 2016, 59 : S498 - S498